Document is current
Any future updates will be listed below
-
Authors
Allgeier, Stephan
Bohn, Sebastian
Mikut, Ralf
Reichert, Klaus-Martin
Stachs, Oliver
Wagner, Elisabeth
Zettl, Uwe Klaus
Sperlich, Karsten
-
Funding
Funding for this research was provided by:
Karlsruher Institut für Technologie (KIT)
- License Information
-
More Information
Article History
Received: 7 February 2025
Accepted: 9 April 2026
First Online: 17 April 2026
Declarations
:
: S.A., S.B., R.M., K.M.R., O.S., E.W. and K.S. declare no competing interests.U.K.Z. has received speaking fees, travel support and/or financial support for research activities from Alexion, Almirall, Bayer, Biogen, Bristol Myers Squibb, Janssen, Merck Serono, Novartis, Octapharm, Roche, Sanofi Genzyme, Teva as well as EU, BMBF, BMWi and DFG. None resulted in a conflict of interest.
